Abstract

Chronic inflammation can have a considerable impact on the progression of glomerular and tubulointerstitial pathologies in chronic kidney disease (CKD). As an alternative to the early detection of inflammatory markers that are most important in the progression of CKD, this study aims to analyze the association of MLR, NLR, and TNF-? with the stages of CKD. This cross-sectional study conducted at Universitas Airlangga Hospital, Surabaya, Indonesia, in mid-2023 involved 65 CKD subjects, consisting of 5 stages of CKD according to KDIGO guidelines. eGFR was calculated using the CKD-EPI creatinine equation. MLR and NLR were calculated from the differential count hematology analyzer Sysmex XN-550. TNF-α was examined using the sandwich ELISA method. Random-spot urine was used for the UACR examination (TMS 24i Premium Chemical Analyzer). There were significant differences in MLR and TNF-α at various stages of CKD (p<0.05), but NLR showed no significant difference at different stages of CKD (p>0.05). There was a significant association between MLR (p<0.001, r = 0.470) and NLR (p = 0.046, r = 0.248) with the stages of CKD. TNF-α was not associated with the stages of CKD. MLR and NLR were not associated with TNF-α at CKD. MLR, NLR, and TNF-α had no significant relationship with UACR (p>0.05). In conclusion, MLR is better for assessing the progression of chronic kidney disease compared to NLR and TNF-α.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.